Short Interest in Gain Therapeutics, Inc. (NASDAQ:GANX) Decreases By 12.6%

Gain Therapeutics, Inc. (NASDAQ:GANX – Get Free Report) was the target of a large decline in short interest during the month of October. As of October 15th, there was short interest totalling 572,000 shares, a decline of 12.6% from the September 30th …